In cases of genetic aberrations in cancers, such as truncating mutations affecting the initiation of TGF-β receptor signaling, like the TβRII frame-shift mutation [31], the TGF-β signaling pathway can be disrupted, thereby tipping the balance towards the extrinsic pro-tumorigenic functions of TGF-βs. This evidence concerns the gene TGFB1 and cancer.